Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$123.91K

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 22, 2026
Public filing date Jun 24, 2026
Filing lag Filed 2 days later

UTHR daily price context

Close on/before transaction
$538.3 Jun 22, 2026
First close after public filing
$543.39 Jun 25, 2026
30-day return after filing
-2.75% Through Jul 24, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
232 shares @ $534.09
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000083
Filing cohort

Transactions in this filing

Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$6.43M
Buys / sales
0 / 7
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 22, 2026 $892.42K
United Therapeutics Corp UTHR Exercise Jun 22, 2026 $424.95K
United Therapeutics Corp UTHR Sale Jun 22, 2026 $532.27K
United Therapeutics Corp UTHR Sale Jun 22, 2026 $607.31K
United Therapeutics Corp UTHR Sale Jun 22, 2026 $537.13K
United Therapeutics Corp UTHR Sale Jun 22, 2026 $1.72M
United Therapeutics Corp UTHR Sale Jun 22, 2026 $1.44M
United Therapeutics Corp UTHR Sale Jun 22, 2026 $146.31K
United Therapeutics Corp UTHR Exercise Jun 22, 2026 $0
United Therapeutics Corp UTHR Exercise Jun 22, 2026 $0
United Therapeutics Corp UTHR Current Sale Jun 22, 2026 $123.91K